Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. September 2011 08:00 ET | Quelle: Cytomedix, Inc.

Cytomedix Submits 510(k) to FDA for Bone Marrow Aspirate Concentrate Indication for Angel System

GAITHERSBURG, Md., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
31. August 2011 08:00 ET | Quelle: Cytomedix, Inc.

Cytomedix Provides Update on Reimbursement Reconsideration Request for Autologous PRP Gel

GAITHERSBURG, Md., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
15. August 2011 16:05 ET | Quelle: Cytomedix, Inc.

Cytomedix Reports Second Quarter Financial Results

GAITHERSBURG, Md., Aug. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
09. August 2011 08:30 ET | Quelle: Cytomedix, Inc.

Cytomedix to Host Second Quarter 2011 Financial Results Conference Call on Tuesday, August 16, 2011

GAITHERSBURG, Md., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
01. August 2011 08:30 ET | Quelle: Cytomedix, Inc.

Positive Data Demonstrating AutoloGel Provides Rapid Improvement in Healing of Complex Chronic Wounds Published in Advances in Skin and Wound Care

GAITHERSBURG, Md., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
20. Juli 2011 16:30 ET | Quelle: Cytomedix, Inc.

Cytomedix Completes Two Convertible Note Financings

GAITHERSBURG, Md., July 20, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
31. Mai 2011 08:00 ET | Quelle: Cytomedix, Inc.

Cytomedix Submits Reimbursement Reconsideration Request to Centers for Medicare & Medicaid Services for Autologous PRP Gel

GAITHERSBURG, Md., May 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
16. Mai 2011 16:27 ET | Quelle: Cytomedix, Inc.

Cytomedix Reports First Quarter Financial Results

GAITHERSBURG, Md., May 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
11. Mai 2011 07:47 ET | Quelle: Cytomedix, Inc.

Cytomedix to Host First Quarter 2011 Financial Results Conference Call on Tuesday, May 17, 2011

GAITHERSBURG, Md., May 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
02. Mai 2011 08:00 ET | Quelle: Cytomedix, Inc.

Cytomedix Retires All Angel Acquisition Debt With New Loan and Equity Financing

GAITHERSBURG, Md., May 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...

Vorherige Seite

Nächste Seite